Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TNOX

Tanox (TNOX)

Tanox (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNOX
DateTimeSourceHeadlineSymbolCompany
08/02/20075:30PMPR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Respiratory/Pulmonary IndexNASDAQ:TNOXTanox (MM)
05/09/20075:02PMPR Newswire (US)Tanox Reports 2007 First Quarter ResultsNASDAQ:TNOXTanox (MM)
03/15/20075:53PMPR Newswire (US)Tanox Reports Fourth Quarter and Full Year 2006 ResultsNASDAQ:TNOXTanox (MM)
01/29/20078:36AMPR Newswire (US)Genentech and Tanox Receive 'Second Request' from the Federal Trade CommissionNASDAQ:TNOXTanox (MM)
01/15/20072:43PMPR Newswire (US)Tanox, Inc. Stockholders Approve Merger With Genentech, Inc.NASDAQ:TNOXTanox (MM)
11/09/20065:50PMPR Newswire (US)Genentech Announces Agreement to Acquire Tanox for $20 Per ShareNASDAQ:TNOXTanox (MM)
11/02/20066:30AMPR Newswire (US)Tanox Reports 2006 Third Quarter ResultsNASDAQ:TNOXTanox (MM)
10/25/20067:00AMPR Newswire (US)Tanox Initiates Phase 1 Clinical Trial Evaluating TNX-650 for Treatment of AsthmaNASDAQ:TNOXTanox (MM)
10/24/20066:10PMPR Newswire (US)Tanox to Report Third Quarter 2006 Financial Results, Host Conference Call for Investors Nov. 2NASDAQ:TNOXTanox (MM)
09/14/20063:03PMPR Newswire (US)Tanox to Present at UBS Global Life Sciences ConferenceNASDAQ:TNOXTanox (MM)
08/31/20068:00AMPR Newswire (US)Tanox to Present at the Bear Stearns Healthcare ConferenceNASDAQ:TNOXTanox (MM)
08/17/20062:00PMPR Newswire (US)New Data Confirm Durable Response of TNX-355 Regimens Through 48 Weeks in Treatment-Experienced HIV PatientsNASDAQ:TNOXTanox (MM)
08/08/20066:30AMPR Newswire (US)Tanox Reports 2006 Second Quarter ResultsNASDAQ:TNOXTanox (MM)
08/03/20066:45PMPR Newswire (US)Tanox Conducts Meeting With Food and Drug Administration Regarding Its HIV/AIDS Antibody, TNX-355NASDAQ:TNOXTanox (MM)
07/18/20069:00AMPR Newswire (US)Tanox to Report Second Quarter 2006 Financial Results, Host Conference Call for Investors Aug. 8NASDAQ:TNOXTanox (MM)
05/31/20067:21PMPR Newswire (US)Results of TNX-355 Combination Study Published in Antimicrobial Agents and ChemotherapyNASDAQ:TNOXTanox (MM)
05/23/20066:00AMPR Newswire (US)First Patient Dosed in Phase 1 Trial of Tanox's TNX-650NASDAQ:TNOXTanox (MM)
05/02/20066:00AMPR Newswire (US)Tanox Reports 2006 First Quarter ResultsNASDAQ:TNOXTanox (MM)
05/02/20065:00AMPR Newswire (US)Tanox Reports 48-Week Results From TNX-355 Phase 2 Clinical TrialNASDAQ:TNOXTanox (MM)
04/17/20064:30PMPR Newswire (US)Tanox to Present at Two Investor Conferences in MayNASDAQ:TNOXTanox (MM)
04/10/20061:00PMPR Newswire (US)Tanox to Report First Quarter 2006 Financial Results, Host Conference Call for Investors May 2NASDAQ:TNOXTanox (MM)
02/28/20066:30AMPR Newswire (US)Tanox Reports Fourth Quarter and Full Year 2005 ResultsNASDAQ:TNOXTanox (MM)
02/09/20062:00PMPR Newswire (US)New Research Reaffirms Tropism Independence of TNX-355; Data for Tanox's Novel HIV Viral Entry Inhibitor Presented at 2006 CROINASDAQ:TNOXTanox (MM)
02/08/200610:30PMPR Newswire (US)Tanox to Report 2005 Fourth Quarter and Full Year Results Feb. 28NASDAQ:TNOXTanox (MM)
02/03/200610:34AMPR Newswire (US)Tanox to Present at Two Investor Conferences in FebruaryNASDAQ:TNOXTanox (MM)
01/23/20067:00AMPR Newswire (US)Tanox Receives Multimillion Xolair(R) Milestone PaymentNASDAQ:TNOXTanox (MM)
01/04/20061:29PMPR Newswire (US)Tanox to Present at JP Morgan Healthcare ConferenceNASDAQ:TNOXTanox (MM)
12/20/20052:14PMPR Newswire (US)Tanox Submits Investigational New Drug Application for TNX-650 for Treatment of Hodgkin's LymphomaNASDAQ:TNOXTanox (MM)
12/17/20051:30PMPR Newswire (US)Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry InhibitorNASDAQ:TNOXTanox (MM)
12/17/200510:30AMPR Newswire (US)Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV TherapyNASDAQ:TNOXTanox (MM)
 Showing the most relevant articles for your search:NASDAQ:TNOX